XML 44 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Debt obligations (Tables)
3 Months Ended
Mar. 31, 2018
Schedule of Short-term Debt

Short-term debt:

 

     Weighted average interest
rate as of March 31, 2018
  Maturity      March 31,
2018
     December 31,
2017
 
                (U.S. $ in millions)  

Term loan JPY 28.3 billion (5)

   JPY LIBOR+0.25%     2018      $ —        $ 251  

Convertible debentures

   0.25%     2026      514        514  

Other

   11.68%     2018        2        1  

Current maturities of long-term liabilities

 

     786        2,880  
  

 

 

    

 

 

 

Total short term debt

 

   $ 1,302      $ 3,646  
  

 

 

    

 

 

 

 

* Net-share settlement feature exercisable at any time.
Schedule of Senior Notes and Loans

Long-term debt includes the following:

 

     Weighted average interest
rate as of March 31, 2018
  Maturity    March 31, 2018      December 31,
2017
 
          
     %        (U.S. $ in millions)  

Senior notes EUR 1,750 million

   0.38%   2020    $ 2,152      $ 2,095  

Senior notes EUR 1,500 million

   1.13%   2024      1,837        1,788  

Senior notes EUR 1,300 million

   1.25%   2023      1,593        1,550  

Senior notes EUR 1,000 million (3)

   2.88%   2019      —          1,199  

Senior notes EUR 900 million (1)

   4.50%   2025      1,109        —    

Senior notes EUR 750 million

   1.63%   2028      915        891  

Senior notes EUR 700 million (1)

   3.25%   2022      863        —    

Senior notes EUR 700 million

   1.88%   2027      859        837  

Senior notes USD 3,500 million

   3.15%   2026      3,492        3,492  

Senior notes USD 3,000 million

   2.20%   2021      2,997        2,996  

Senior notes USD 3,000 million

   2.80%   2023      2,992        2,992  

Senior notes USD 2,000 million

   1.70%   2019      2,000        2,000  

Senior notes USD 2,000 million

   4.10%   2046      1,984        1,984  

Senior notes USD 1,500 million (3)

   1.40%   2018      —          1,500  

Senior notes USD 1250 million (2)

   6.00%   2024      1,250        —    

Senior notes USD 1250 million (2)

   6.75%   2028      1,250        —    

Senior notes USD 844 million

   2.95%   2022      863        864  

Senior notes USD 789 million

   6.15%   2036      781        781  

Senior notes USD 700 million

   2.25%   2020      700        700  

Senior notes USD 613 million

   3.65%   2021      623        624  

Senior notes USD 588 million

   3.65%   2021      587        587  

Senior notes CHF 450 million

   1.50%   2018      472        461  

Senior notes CHF 350 million

   0.50%   2022      367        360  

Senior notes CHF 350 million

   1.00%   2025      368        360  

Senior notes CHF 300 million

   0.13%   2018      314        308  

Fair value hedge accounting adjustments

     (16      (2
       

 

 

    

 

 

 

Total senior notes

     30,352        28,367  

Term loan USD 2.5 billion (4)

   LIBOR +1.1375%   2018      —          285  

Term loan USD 2.5 billion (4)

   LIBOR +1.50%   2017-2020      —          2,000  

Term loan JPY 58.5 billion (5)

   JPY LIBOR +0.55%   2022      —          519  

Term loan JPY 35 billion (6)

   1.42%   2019      —          311  

Term loan JPY 35 billion (6)

   JPY LIBOR +0.3%   2018      —          311  
       

 

 

    

 

 

 

Total loans

     —          3,426  

Debentures USD 15 million (7)

   7.20%   2018      —          15  

Other

   7.31%   2026      5        5  
  

 

 

    

 

 

 

Total debentures and others

     5        20  
       

 

 

    

 

 

 

Less current maturities

     (786      (2,880

Derivative instruments

     16        2  

Less debt issuance costs

     (137      (106
  

 

 

    

 

 

 

Total long-term debt

   $ 29,450      $ 28,829  
  

 

 

    

 

 

 

 

Debt development

 

(1) In March 2018, Teva Pharmaceutical Finance Netherlands II B.V., a Teva finance subsidiary, issued senior notes in an aggregate principal amount of €1.6 billion.

 

(2) In March 2018, Teva Pharmaceutical Finance Netherlands III B.V., a Teva finance subsidiary, issued senior notes in an aggregate principal amount of $2.5 billion.

 

(3) In March 2018, Teva redeemed in full its $1.5 billion 1.4% senior notes due in July 2018 and its €1.0 billion 2.88% senior notes due in April 2019.

 

(4) During the first quarter of 2018, Teva prepaid approximately $2.3 billion principal amount of the remaining term loan facilities.

 

(5) During the first quarter of 2018, Teva prepaid in full JPY 86.8 billion principal amount of the outstanding term loan facilities of which JPY 28.3 billion were in short-term debt as of December 31, 2017.

 

(6) During the first quarter of 2018, Teva prepaid in full JPY 70 billion of its 1.42% and JPY LIBOR+0.3% outstanding term loans.

 

(7) During the first quarter of 2018, Teva prepaid in full $15 million of its outstanding debentures.